111Category: |
Pharmaceuticals and Biochemicals |
|
CAS NO: |
2068-78-2 |
EC NO: |
218-190-0 |
Molecular Formula: |
C46H58N4O14S |
Molecular Weight: |
923.0361 |
Specification: |
|
InChI: |
InChI=1/C46H56N4O10.H2O4S/c1-7-42(55)22-28-23-45(40(53)58-5,36-30(14-18-48(24-28)25-42)29-12-9-10-13-33(29)47-36)32-20-31-34(21-35(32)57-4)50(26-51)38-44(31)16-19-49-17-11-15-43(8-2,37(44)49)39(60-27(3)52)46(38,56)41(54)59-6;1-5(2,3)4/h9-13,15,20-21,26,28,37-39,47,55-56H,7-8,14,16-19,22-25H2,1-6H3;(H2,1,2,3,4)/t28?,37-,38+,39+,42-,43+,44+,45-,46-;/m0./s1 |
Product description:
An anticancer drug. Odorless.Treatment of acute leukemia, hodgkin's disease, soft-tissue sarcoma, bony-tissue sarcoma, sarcomas of specialized structures, breast cancer, small cell cancer of the lung, cancer of the uterine cervix, malignant melanoma, colorectal cancer, non-hodgkin's lymphoma and wilms' tumor. |
Synonyms: |
Vincristine Sulfate, Apocynaceae sp.;Vincristine Sulphate;Vincristine sulfate salt;22-Oxovincaleukoblastine sulfate salt; Leurocristine sulfate salt;(2alpha,2'beta,3alpha,4alpha,5beta,19beta)-22-oxovincaleukoblastine;(2alpha,2'beta,3alpha,4alpha,5beta,19beta)-22-oxovincaleukoblastine sulfate (1:1);(2alpha,2'beta,3alpha,4alpha,5beta,19beta)-22-oxovincaleukoblastine sulfate;(2alpha,3alpha,4alpha,5beta,19beta)-22-oxovincaleukoblastine sulfate; |
Molecular Structure: |
![Vincristine sulfate 2068-78-2](https://images-a.chemnet.com/suppliers/chembase/663/6635.gif) |